Study Summary
This trial will evaluate a mobile platform to help healthcare workers cope with stress and depression during and after the COVID-19 pandemic. Personalized interventions will be used to manage distress. #mentalhealth #COVID19
Eligible Conditions
- Depression
- Anxiety
- Stress
- Loneliness
Treatment Effectiveness
Phase-Based Effectiveness
N/A
Study Objectives
0 Primary · 6 Secondary · Reporting Duration: At 4 weeks from baseline
Week 12
Perceived Stress Scale
Week 4
Active Data - Generalized Anxiety Disorder Scale
Active Data - Patient Health Questionnaire
Active Data - Short UCLA Loneliness Scale
Passive Data - Feasibility of Collection of Passive Data - GPS Mobility
Passive Data - GPS Sample Point Metrics
Trial Safety
Phase-Based Safety
Awards & Highlights
No Placebo Group
All patients enrolled in this trial will receive the new treatment.
Trial Design
2 Treatment Groups
Control Group
1 of 2
Mobile Intervention Group
1 of 2
Active Control
Experimental Treatment
50 Total Participants · 2 Treatment Groups
Primary Treatment: Mobile Intervention · No Placebo Group · N/A
Mobile Intervention Group
Other
Experimental Group · 1 Intervention: Mobile Intervention · Intervention Types: OtherControl GroupNoIntervention Group · 1 Intervention: Control Group · Intervention Types:
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: at 4 weeks from baseline
Who is running the clinical trial?
Ryerson UniversityOTHER
76 Previous Clinical Trials
7,874 Total Patients Enrolled
5 Trials studying Depression
632 Patients Enrolled for Depression
University of TorontoOTHER
648 Previous Clinical Trials
733,515 Total Patients Enrolled
21 Trials studying Depression
48,414 Patients Enrolled for Depression
Unity Health TorontoLead Sponsor
510 Previous Clinical Trials
377,457 Total Patients Enrolled
14 Trials studying Depression
2,998 Patients Enrolled for Depression
Venkat Bhat, MD MScPrincipal InvestigatorUnity Health Toronto
3 Previous Clinical Trials
65 Total Patients Enrolled
1 Trials studying Depression
30 Patients Enrolled for Depression
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: